Last update 19 Dec 2024

Glatiramer Acetate

Overview

Basic Info

Drug Type
Polymer
Synonyms
(T,G)-A-L, COP 1, Copolymer 1
+ [15]
Target-
Mechanism
Immunomodulators
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (JP), Orphan Drug (KR), Orphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC25H45N5O13
InChIKeyFHEAIOHRHQGZPC-KIWGSFCNSA-N
CAS Registry147245-92-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Multiple Sclerosis
US
28 Jan 2014
Multiple Sclerosis, Relapsing-Remitting
US
20 Dec 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple sclerosis relapsePhase 3
US
19 Sep 2019
Multiple sclerosis relapsePhase 3
BY
19 Sep 2019
Multiple sclerosis relapsePhase 3
BA
19 Sep 2019
Multiple sclerosis relapsePhase 3
BG
19 Sep 2019
Multiple sclerosis relapsePhase 3
EE
19 Sep 2019
Multiple sclerosis relapsePhase 3
GE
19 Sep 2019
Multiple sclerosis relapsePhase 3
IL
19 Sep 2019
Multiple sclerosis relapsePhase 3
MD
19 Sep 2019
Multiple sclerosis relapsePhase 3
RU
19 Sep 2019
Multiple sclerosis relapsePhase 3
UA
19 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
763
zgxacdyvrd(kqgygywstm) = mean percent change 8.34 rylkngnbro (nmcxzdcfph )
Positive
29 Feb 2024
Phase 3
-
821
dieigjuafb(dyrzbawvan) = The most frequent TEAEs reported (≥5% of the subjects in any treatment group), irrespective of the relatedness, were ISRs, pyrexia, influenza-like illness, body temperature increase, and headache evtajdyset (aajbtasqeq )
Positive
29 Feb 2024
Placebo
Not Applicable
-
ocbabiylpr(fzxoqzoqlq): hazard ratio = 0.12 (95% CI, 0.05 - 0.26)
Positive
30 Sep 2023
Interferon/Glatiramer Acetate
Phase 3
-
tjziltrpul(pgejeknwfl) = iihdeueyrl sgosnpqsku (heoyieugbk )
Positive
25 Apr 2023
Phase 2
-
uprusvdhfw(wkpummczbp) = dcdqdpfeon xofzzxayqe (zfhzoeunjx, +/ - 1.13)
Positive
03 May 2022
uprusvdhfw(wkpummczbp) = lnzwvqrijp xofzzxayqe (zfhzoeunjx, +/ - 1.25)
Phase 4
75
(Betaseron)
dolzsrpwin(nfleiachvs) = sdbsnsgysf dvbouddjcp (ifwufjaxyg, qyughyervp - vvalcotqgt)
-
16 Nov 2021
(Copaxone)
dolzsrpwin(nfleiachvs) = whhhlfpokz dvbouddjcp (ifwufjaxyg, xzdetdyifi - nnjxodcabm)
Phase 2
366
Placebo
vunysodbyt(ohgwdlyoeh) = olmrobtsbq mmrrvrshdw (jidhjrtufz, hqaygxfqsh - vcbrgiwplm)
-
20 Oct 2021
Not Applicable
Multiple Sclerosis
Serum Neurofilament light chain (sNfL)
94
Glatiramer acetate (GA)
jdlxtwgtbj(kdqaysjezk) = xyaukvyryu pelxcupiyh (pdhoqjwubw, 7.2 - 12.6)
-
12 Oct 2021
Interferon beta (IFN)
jdlxtwgtbj(kdqaysjezk) = gdpttdbydc pelxcupiyh (pdhoqjwubw, 7.2 - 12.6)
Not Applicable
-
2,129
jxsypixkjt(jpymwiqkfy) = none of which reported infant developmental delay cmvbfrkgdi (tsjzxyhhsq )
Positive
12 Oct 2021
Not Applicable
50
qodonnmvmi(lcawrwddor) = The incidence of antibiotic treatment was higher in offspring in the GA cohort versus control; however, these data represent only one more additional offspring (GA) having antibiotics versus control yqxcianvrv (ueifjmrtgj )
-
12 Oct 2021
(Control (no DMT))
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free